Takeda Pharmaceutical
TAK
$13.22
Share price
-0.68%
Change (1 day)
-18.80%
Change (1 year)
Categories
Market capitalization of Takeda Pharmaceutical (TAK)
Market cap: $41.78 Billion
As of May 2024 Takeda Pharmaceutical has a market cap of $41.78 Billion. This makes Takeda Pharmaceutical the world's 478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Takeda Pharmaceutical from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $41.78 B | -7.26% |
| 2023 | $45.05 B | -7.11% |
| 2022 | $48.50 B | 13.56% |
| 2021 | $42.71 B | -24.96% |
| 2020 | $56.92 B | -8.14% |
| 2019 | $61.96 B | 136.23% |
| 2018 | $26.23 B | -40.77% |
| 2017 | $44.29 B | 35.96% |
| 2016 | $32.57 B | -17.68% |
| 2015 | $39.57 B | 19.85% |
| 2014 | $33.02 B | -9.04% |
| 2013 | $36.30 B | 2.57% |
| 2012 | $35.39 B | 1.67% |
| 2011 | $34.81 B | -9.45% |
| 2010 | $38.44 B | 18.49% |
| 2009 | $32.44 B | -29.16% |
| 2008 | $45.79 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Takeda Pharmaceutical was reported to be:
$41.78 Billion
$41.78 Billion
$41.51 Billion
$41.83 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $372.16 B | 790.68% | 🇺🇸 USA |
 Novartis NVS | $209.58 B | 401.57% | 🇨🇭 Switzerland |
 Pfizer PFE | $162.29 B | 288.40% | 🇺🇸 USA |
 Amgen AMGN | $167.61 B | 301.15% | 🇺🇸 USA |
 Sanofi SNY | $122.00 B | 192.00% | 🇫🇷 France |
 Merck MRK | $332.27 B | 695.21% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $94.75 B | 126.77% | 🇬🇧 UK |
 Seagen
SGEN | $43.15 B | 3.28% | 🇺🇸 USA |
 Dr. Reddy's RDY | $11.48 B | -72.51% | 🇮🇳 India |